These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8323302)

  • 21. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M; Lespinasse F; Malaise EP
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
    Thanislass J; Raveendran M; Devaraj H
    Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
    Kang YJ
    Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of nitroglycerin depend on both plasma and intracellular sulfhydryl compound levels in vivo. Effect of agents with different sulfhydryl-modulating properties.
    Boesgaard S; Poulsen HE; Aldershvile J; Loft S; Anderson ME; Meister A
    Circulation; 1993 Feb; 87(2):547-53. PubMed ID: 8425299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione oxidation and embryotoxicity elicited by diamide in the developing rat conceptus in vitro.
    Hiranruengchok R; Harris C
    Toxicol Appl Pharmacol; 1993 May; 120(1):62-71. PubMed ID: 8511783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid-mixing studies of radiosensitivity with thiol-depleted mammalian cells.
    Hodgkiss RJ; Roberts IJ; Watts ME; Woodcock M
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Nov; 52(5):735-44. PubMed ID: 3500144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide.
    Obin M; Shang F; Gong X; Handelman G; Blumberg J; Taylor A
    FASEB J; 1998 May; 12(7):561-9. PubMed ID: 9576483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is enhanced free radical flux associated with increased intracellular proteolysis?
    Vince GS; Dean RT
    FEBS Lett; 1987 Jun; 216(2):253-6. PubMed ID: 3034677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells.
    Jornot L; Junod AF
    Am J Physiol; 1993 May; 264(5 Pt 1):L482-9. PubMed ID: 8498525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of manganese superoxide dismutase gene expression by thioredoxin.
    Das KC; Lewis-Molock Y; White CW
    Am J Respir Cell Mol Biol; 1997 Dec; 17(6):713-26. PubMed ID: 9409558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
    Lee KS; Kim HK; Moon HS; Hong YS; Kang JH; Kim DJ; Park JG
    Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL; Wedner HJ
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW; Beyers KL
    Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.